Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Role of Early Blood KLK10 and Other Neuroinflammatory Molecules on Clinical Outcomes of Acute Ischemic Stroke

NCT06549972 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT06549972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06549972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Role of Early Blood KLK10 and Other Neuroinflammatory Molecules on Clinical Outcomes of Acute Ischemic Stroke
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Completed
Start date
August 12, 2024
Completion date
June 30, 2025
Enrollment
273 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke